Syndax Pharmaceuticals, Inc. (SNDX)
20.47
-0.25
(-1.21%)
USD |
NASDAQ |
Jan 13, 16:00
20.44
-0.03
(-0.15%)
After-Hours: 20:00
Syndax Pharmaceuticals Research and Development Expense (Quarterly): 56.28M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 19.60M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Puma Biotechnology, Inc. | 15.91M |
| Krystal Biotech, Inc. | 13.18M |
| Sutro Biopharma, Inc. | 39.85M |